NASDAQ
70.21USD
+0.38 (+0.54%)
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
2.7B
P/E
—
EPS
—
Beta
2.10
52W range
40-99.5
Day range
69.14–71.81
Open
70.12
Prev close
69.83
Volume
681.4K
Avg volume
465.8K
Dividend
0.00
IPO
2020-08-12
https://www.prnewswire.com/news-releases/rosen-law-firm-encourages-disc-medicine-inc-investors-to-inquire-about-securities-class-action-investigation--iron-302799479.html · 6/14/2026-1.00
https://www.prnewswire.com/news-releases/rosen-law-firm-encourages-disc-medicine-inc-investors-to-inquire-about-securities-class-action-investigation--iron-302794508.html · 6/9/2026-1.00
https://www.prnewswire.com/news-releases/rosen-law-firm-encourages-disc-medicine-inc-investors-to-inquire-about-securities-class-action-investigation--iron-302790850.html · 6/4/2026-1.00
https://www.newsfilecorp.com/release/299493/ROSEN-A-LEADING-LAW-FIRM-Encourages-Veritone-Inc.-Investors-to-Secure-Counsel-Before-Important-Deadline-in-Securities-Class-Action-VERI · 6/1/2026-0.80
https://www.newsfilecorp.com/release/298948/ROSEN-TRUSTED-INVESTOR-COUNSEL-Encourages-Graphic-Packaging-Holding-Company-Investors-to-Secure-Counsel-Before-Important-Deadline-in-Securities-Class-Action-GPK · 5/26/2026-1.00
https://www.newsfilecorp.com/release/298713/ROSEN-TOP-RANKED-INVESTOR-COUNSEL-Encourages-Barclays-PLC-Investors-to-Inquire-About-Securities-Class-Action-Investigation-BCS · 5/25/2026-0.70
https://www.newsfilecorp.com/release/298119/LU-DEADLINE-ROSEN-A-LEADING-LAW-FIRM-Encourages-Lufax-Holding-Ltd-Investors-to-Secure-Counsel-Before-Important-May-20-Deadline-in-Securities-Class-Action-First-Filed-by-the-Firm-LU · 5/19/2026-0.80
https://www.newsfilecorp.com/release/298116/ROSEN-A-LEADING-INVESTOR-RIGHTS-LAW-FIRM-Encourages-Graphic-Packaging-Holding-Company-Investors-to-Secure-Counsel-Before-Important-Deadline-in-Securities-Class-Action-GPK · 5/19/2026-0.50
https://www.prnewswire.com/news-releases/rosen-law-firm-encourages-disc-medicine-inc-investors-to-inquire-about-securities-class-action-investigation--iron-302768750.html · 5/12/2026-1.00
https://www.globenewswire.com/news-release/2026/05/11/3291529/673/en/IRON-Investor-News-If-You-Have-Suffered-Losses-in-Disc-Medicine-Inc-NASDAQ-IRON-You-Are-Encouraged-to-Contact-The-Rosen-Law-Firm-About-Your-Rights.html · 5/11/2026-1.00
https://www.newsfilecorp.com/release/296132/ROSEN-A-LEADING-LAW-FIRM-Encourages-Hercules-Capital-Inc.-Investors-to-Secure-Counsel-Before-Important-Deadline-in-Securities-Class-Action-HTGC · 5/5/2026-1.00
https://www.newsfilecorp.com/release/295703/ROSEN-A-GLOBAL-INVESTOR-RIGHTS-LAW-FIRM-Encourages-Barclays-PLC-Investors-to-Inquire-About-Securities-Class-Action-Investigation-BCS · 5/4/2026-0.50
Based in Watertown, Massachusetts, Disc Medicine, Inc. operates as a clinical-stage biotechnology company. Its core mission involves the discovery, development, and commercialization of novel therapeutic solutions for individuals suffering from serious hematological diseases. The company is actively constructing a pipeline of drug candidates, designed to address a variety of these conditions by precisely targeting fundamental biological mechanisms related to red blood cell biology, particularly heme biosynthesis and iron homeostasis.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
